Revenue segments as reported by the company.

Cannabis revenue

Distribution revenue

Beverage alcohol revenue

Wellness revenue

Adult-use

Canada - Medical

International - Medical

Bulk

Hemp

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Impairment of Assets

Litigation settlement

Transaction costs

Change in fair value of contingent consideration

Restructuring costs

Other than temporary change in fair value of convertible notes receivable

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Tilray Brands

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America. The firm is focused on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment consists of hemp seed, hemp foods, and broad spectrum hemp extract containing CBD, which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Earnings data Q1 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Tilray Brands reports record revenue and optimistic outlook for 2025

Tilray Brands achieved remarkable financial performance in Q4 2024, driven by strategic acquisitions and a focus on innovation. Despite challenges like price compression, the company remains optimistic about future growth opportunities. Tilray's commitment to quality products and innovation positions it well for continued success in the market.

Tilray Brands reports record Q1 revenue growth and global expansion

Tilray Brands delivered a robust performance in Q1 2025, showcasing strong revenue growth, margin improvement, and strategic expansion across its diversified product portfolio.
While facing challenges in a competitive landscape and evolving regulatory environment, Tilray's financial strength, international growth initiatives, and focus on innovation position it well for future success.
By capitalizing on opportunities in wellness products, expanding into new beverage categories, and leveraging strategic partnerships, Tilray is poised for continued growth and market leadership.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. The Cannabis Business segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution Business segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage Alcohol Business segment refers to the production, marketing, and sale of beverages. The Wellness Business segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Aurora Cannabis

HEXO Corp

OrganiGram Holdings Inc.

SNDL Inc.

Some of these beaten-down cannabis stocks could start to reverse their fortunes next year.

Investors in These 5 Marijuana Stocks Had a Rough 2020

Both of these cannabis companies have lost more than half their value this year, but they could still bounce back.

2 Ultra-Risky Pot Stocks That Could Make You Filthy Rich

Chipotle

Dollar General

Moderna

Pinduoduo Inc - ADR

SolarEdge Technologies

These hot stocks to buy by Jan. 1 have the potential to deliver short-term returns in addition to long-term gains throughout 2021. The post 7 Hot Stocks to Buy by Jan. 1 appeared first on InvestorPlace.

7 Hot Stocks to Buy by Jan. 1

Thinking of buying pot stocks for the new year? Check out these two companies and their soaring revenues.

The 2 Best Cannabis Stocks to Own in 2021

Aphria

This isn't the first time Aphria has been involved in a potential deal.

Pot Stock Mega-Merger: What Should Investors Know About Aphria and Tilray?

WILMINGTON, Del., Dec. 18, 2020 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it is investigating Tilray, Inc. (“Tilray”) (NASDAQ GS: TLRY) regarding possible breaches of fiduciary duties and other violations of law related to Tilray's agreement to merge with Aphria Inc. (“Aphria”) (NASDAQ: APHA).  

SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Tilray, Inc. Merger

Pot stocks are warming up again thanks to the Biden victory and Aphria-Tilray merger. But several challenges still remain for Tilray stock.

The Tilray-Aphria Merger Is A Big Deal For Legalized Cannabis Bulls

After a brutal start to the year for cannabis investors, the ETF MANAGERS TR/TIERRA XP LATIN AME (NYSE: MJ) has rallied 36% in the past three months, propelled in large part by bullish U.S. election results in November. This week, shares of Tilray Inc (NASDAQ: TLRY) rallied after the company announced a merger with Canadian competitor Aphria Inc (NASDAQ: APHA).

Cannabis Short Sellers Now Down $473M In 2020 Following Tilray-Aphria Merger

NEW YORK, Dec. 16, 2020 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Tilray, Inc. ("Tilray" or the "Company") (NASDAQ: TLRY) in connection with the Company's proposed merger with Aphria Inc....

SHAREHOLDER ALERT: WeissLaw LLP Investigates Tilray, Inc.

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLP, a global investor rights law firm, is investigating whether the merger of Tilray, Inc. (NASDAQ: TLRY) and Aphria Inc. is fair to Tilray shareholders. Halper Sadeh encourages Tilray shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com. Under the terms of the merger agreement, Aphria shareholders will receive 0.8381 s

Tilray Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Merger of Tilray, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – TLRY

The shares of Aphria Inc (NASDAQ:APHA) and Tilray Inc (NASDAQ:TLRY) are both significantly higher, after the two Canadian cannabis companies announced an all-stock merger to become the world's largest cannabis producer.

2 Pot Stocks Buzzing on M&A Update

The new company, to be called Tilray, will have significant competitive advantages.

Tilray and Aphria to Merge, Creating Largest Marijauna Company in the World

Shares of Canadian cannabis growers Aphria Inc.and Tilray Inc. are trading sharply higher on Wednesday, following news about the two companies merging to create the largest enterprise in the industry by revenue.

Exclusive: Aphria, Tilray CEOs Discuss Merger, Hiring And 'No Massive Layoffs'

Luminar Technologies

The stock market largely took a breather on Wednesday morning.

Luminar Rebuts Mobileye Rumors; Tilray Does Deal as Nasdaq Inches Higher

Aphria Inc. and Tilray Inc. have agreed to merge in a deal that forms the world's largest cannabis company.

Aphria creates world's largest marijuana dealer with $3.9B Tilray merger

Marijuana producers Tilray and Aphria announced plans to merge Wednesday in a deal that will create a $4 billion cannabis colossus. The combined company will boast $685 million in annual revenue, making it the world's biggest player in a fast-growing industry, the Canadian firms said.

Marijuana producers Tilray, Aphria merge to form world's largest cannabis firm

The marijuana industry got a jolt Wednesday morning following the announcement of a reverse merger of Aphria Inc.

What a Reverse Merger of Aphria and Tilray Means for the Marijuana Market

Aphria and Tilray announced a merger Wednesday that would create the biggest weed company by revenue. The post Aphria, Tilray To Form Largest Cannabis Company By Sales In Merger appeared first on Investor's Business Daily.

Aphria, Tilray To Form Largest Cannabis Company By Sales In Merger

Aphria Inc. (TSE: APHA) announced a reverse merger with its competitor, Tilray Inc. (NASDAQ: TLRY) on Wednesday – a move that will establish the largest cannabis producer in terms of sales. The Canadian company also said that the merger will help it expand its footprint in the U.S. market that has been growing rapidly in recent years.

Aphria and Tilray to merge and create the largest cannabis producer by sales

The combined company has equity value of $3.9 billion and revenue of $685 million in the last year.

Aphria and Tilray Combine to Create World's Biggest Cannabis Company

Shares of Tilray Inc. soared Wednesday, after company announced a deal to merger with Aphria Inc. in a deal that is expected to create the world's largest cannabis company, with a combined equity value of about $3.9 billion.

Cannabis Watch: Tilray stock rockets after reverse merger deal with Aphria, to create largest global cannabis company

Tilray rallied as much as 29% in early Wednesday trading after the company announced plans to merge with Aphria and create the world's biggest marijuana company. The two firms announced Wednesday they agreed to combine as a $3.9 billion firm focused on the global production and distribution of cannabis. Aphria shareholders will receive 0.8381 shares of Tilray for each Aphria share they hold, representing a 23% premium to Tilray's Tuesday closing price.

Tilray surges 29% after $4 billion merger with Aphria creates the world's biggest cannabis company

Tilray stock and Aphria stock are soaring on news that the two cannabis companies will form one, trading as TLRY stock. The post Tilray Stock: TLRY and Aphria Stock Soar on Cannabis Merger News appeared first on InvestorPlace.

Tilray Stock: TLRY and Aphria Stock Soar on Cannabis Merger News

Aphria and Tilray are moving toward a landmark merger agreement.

Why Aphria and Tilray Are Soaring Today

Shares of Tilray Inc. soared 30.8% in premarket trading and Aphria Inc.'s U.S.-listed stock surged 9.9%, after the Canada-based cannabis companies announced a merger, which they say will create the largest global cannabis company, with a combined equity value of about $3.9 billion. After the deal closes, which the companies said was structured has a "reverse acquisition" of Tilray, Aphria shareholders will own 62% of outstanding Tilray shares.

News for Tilray Brands Stock (TLRY)